Showing results (471-480 of 601) with videos related to
Sort By:
Pageof 61
Communications Biology|July 23, 2021
Metabolomic signatures associated with depression and predictors of antidepressant response in humans: A CAN-BIND-1 reportGiorgia Caspani, Gustavo Turecki, Raymond W Lam, et al.Nature Communications|November 26, 2015
Mitotic cells contract actomyosin cortex and generate pressure to round against or escape epithelial confinementBarbara Sorce, Carlos Escobedo, Yusuke Toyoda, et al.The Journal of Biological Chemistry|March 29, 2008
Structural properties of AMP-activated protein kinase: dimerization, molecular shape, and changes upon ligand bindingUwe Riek, Roland Scholz, Peter Konarev, et al.The Journal of Biological Chemistry|May 8, 2003
Type III protein translocase: HrcN is a peripheral ATPase that is activated by oligomerizationCharalambos Pozidis, Aggeliki Chalkiadaki, Amalia Gomez-Serrano, et al.Human Psychopharmacology|August 9, 2011
Genetic interactions in the adrenergic system genes: analysis of antipsychotic-induced weight gainVincenzo De Luca, Renan P Souza, Emanuela Viggiano, et al.The International Journal of Neuropsychopharmacology|September 9, 2006
Association study of tardive dyskinesia and twelve DRD2 polymorphisms in schizophrenia patientsClement C Zai, Rudi W Hwang, Vincenzo De Luca, et al.Progress in Neuro-Psychopharmacology & Biological Psychiatry|September 26, 2009
Oxidative stress in tardive dyskinesia: genetic association study and meta-analysis of NADPH quinine oxidoreductase 1 (NQO1) and Superoxide dismutase 2 (SOD2, MnSOD) genesClement C Zai, Arun K Tiwari, Vincenzo Basile, et al.Progress in Neuro-Psychopharmacology & Biological Psychiatry|May 31, 2012
The role of brain-derived neurotrophic factor (BDNF) gene variants in antipsychotic response and antipsychotic-induced weight gainGwyneth C M Zai, Clement C H Zai, Nabilah I Chowdhury, et al.Journal of Clinical Pharmacology|October 21, 2009
Effect of age, weight, and CYP2C19 genotype on escitalopram exposureYuyan Jin, Bruce G Pollock, Ellen Frank, et al.Pharmacopsychiatry|March 2, 2021
Impacts on Quality of Life with Escitalopram Monotherapy and Aripiprazole Augmentation in Patients with Major Depressive Disorder: A CAN-BIND ReportEmma Morton, Venkat Bhat, Peter Giacobbe, et al.Pageof 61